摘要
背景:类风湿性关节炎(rheumatoid arthritis,RA)是一种复杂多变的慢性病,具有进行性关节破坏,畸形和残疾的特点。它不仅与遗传有关,而且与环境因素有关。许多研究表明RA来源的成纤维细胞样滑膜细胞(RA-FLS)参与RA的致病过程。 RA-FLS的凋亡和增殖在RA的发生发展中具有重要意义。目前,越来越多的中药(TCM)或天然产品被用于RA的治疗。 目的:研究几种天然产物对α-mangostin诱导RA-FLS MH7A细胞凋亡的影响及其作用机制。 方法:MTT法检测天然产物对MH7A细胞的影响。采用膜联蛋白V-FITC / PI双标记和DAPI染色观察α-mangostin诱导的细胞凋亡。 Western blotting检测凋亡相关蛋白。通过DHE染色测定ROS积聚。 结果:Xantones(包括Garcinone C,α-mangostin和γ-mangostin)显着抑制MH7A细胞活力。 α-倒捻子素诱导MH7A细胞凋亡。进一步的研究表明,α-mangostin能增加Bax / Bcl-2比值,增加MH7A细胞内ROS的产生。 结论:α-Mangostin通过增加ROS积累和Bax / Bcl-2比值诱导MH7A细胞凋亡,提示α-mangostin有利于RA的治疗。
关键词: 类风湿性关节炎,天然产物,MH7A细胞,凋亡,α-倒捻子素,活性氧积累。
Current Molecular Medicine
Title:α-Mangostin, A Natural Xanthone, Induces Apoptosis and ROS Accumulation in Human Rheumatoid Fibroblast-Like Synoviocyte MH7A Cells
Volume: 17 Issue: 5
关键词: 类风湿性关节炎,天然产物,MH7A细胞,凋亡,α-倒捻子素,活性氧积累。
摘要: Background: Rheumatoid arthritis (RA) is a complicated and heterogeneous chronic disease with the characteristic of progressive joint destruction, deformity and disability. It is associated with not only genetic but also environmental factors. Many studies suggest that RA-derived fibroblast-like synoviocyte (RA-FLS) is involved in the pathogenic process of RA. The apoptosis and proliferation of RA-FLS is of great importance in the development and progression in RA. Nowadays, more and more traditional Chinese medicine (TCM) or natural products are studied in the treatment of RA.
Objective: To investigate the effects of several natural products and the apoptosisinduced effect of α-mangostin and its underlying mechanisms in RA-FLS MH7A cells.
Methods: The effects of natural products on MH7A cells were detected by MTT assay. Annexin V-FITC/PI double labeling and DAPI staining were adopted to observe the apoptosis induced by α-mangostin. The apoptosis related proteins were measured with western blotting analysis. ROS accumulation was determined by DHE staining.
Results: Xantones, including Garcinone C, α-mangostin and γ-mangostin, significantly inhibited the MH7A cell viability. And α-mangostin induces apoptosis in MH7A cells. Further study showed that α-mangostin increased the ratio of Bax/Bcl-2 and increased the ROS generation in MH7A cells.
Conclusion: α-Mangostin induces the apoptosis of MH7A cells through increasing ROS accumulation and the ratio of Bax/Bcl-2, suggesting that α-mangostin should be benefit to the therapy of RA.
Export Options
About this article
Cite this article as:
α-Mangostin, A Natural Xanthone, Induces Apoptosis and ROS Accumulation in Human Rheumatoid Fibroblast-Like Synoviocyte MH7A Cells, Current Molecular Medicine 2017; 17 (5) . https://dx.doi.org/10.2174/1566524018666171205123220
DOI https://dx.doi.org/10.2174/1566524018666171205123220 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Current Drug Targets 6-Chloro-7-methyl-3', 4'-dimethoxyflavone – a Potent Selective COX-2 Inhibitor
Medicinal Chemistry Editorial:
Endocrine, Metabolic & Immune Disorders - Drug Targets MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Production of 68Ga-citrate Based on a SnO2 Generator for Short-Term Turpentine Oil-Induced Inflammation Imaging in Rats
Current Radiopharmaceuticals Stress Hormone-Mediated DNA Damage Response -- Implications for Cellular Senescence and Tumour Progression
Current Drug Targets Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies
Mini-Reviews in Medicinal Chemistry Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs
Current Topics in Medicinal Chemistry VEGF, Angiopoietin-1 and -2 in Bronchial Asthma: New Molecular Targets in Airway Angiogenesis and Microvascular Remodeling
Recent Patents on Inflammation & Allergy Drug Discovery Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects
CNS & Neurological Disorders - Drug Targets Autoimmune Hepatitis After Long-Term Methotrexate Therapy for Rheumatoid Arthritis
Current Drug Safety Knowing is Half the Battle: Targeting Virulence Factors of Group A Streptococcus for Vaccine and Therapeutics
Current Drug Targets Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNFα Drug
Current Drug Safety Somatostatin: A Hormone for the Heart?
Current Vascular Pharmacology Integration of Virtual and High Throughput Screening in Lead Discovery Settings
Combinatorial Chemistry & High Throughput Screening Design Strategies, Structures and Molecular Interactions of Small Molecule Src Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Cytokine Targeting in Osteoarthritis
Current Drug Targets Chondromodulin-I and Tenomodulin: The Negative Control of Angiogenesis in Connective Tissue
Current Pharmaceutical Design Environmental (Lifestyle) Risk Factors for LADA
Current Diabetes Reviews